Abstract
Introduction

Replacing lost or severed parts of the body or restoring their function is the goal of regenerative medi
or collagen gel [3] , or keratinocyte sheet grafts [4] . Over the past 15 [5] . Growth factors are small proteins that can be synthesized by a wide variety of cells and play an important role in the regulation of cell proliferation, migration, differentiation and matrix synthesis [6] . [6] . Topical application of recombinant growth factors has shown some clinical benefit, resulting in an FDA approval for recombinant Platelet-derived growth factor Regranex ® for the treatment of diabetic foot ulcers [7] . On the other hand, application of growth factors as recombinant proteins is associated with drawbacks such as short half-life, low bioavailability, enzymatic inactivation and high cost of production [8] . [12] , electroporation [13] , particle bombardment [14] and cationic liposomes [15] . Non-viral 
Because of their crucial role in regenerative processes such as soft tissue repair, bone formation, cartilage healing and nerve regeneration, considerable efforts have been undertaken to administer a large number of different growth factors
Using gene transfer techniques, the localized, long-term production of therapeutic levels of the desired cytokine may be achieved without the disadvantages of recombinant protein application. Given these reasons, gene transfer of cytokines for the purpose of tissue regeneration is of great interest. The aim of this review is to outline possible applications of gene therapy as far as they apply to tissue engineering as well as basic principles of gene therapy, vectors and gene delivery.
Methods of gene delivery
Result
Increased granulation tissue formation [101] Granulation tissue and epithelialisation [102] Prolonged EGF-expression in vivo [39] Accelerated re-epithelialization [43] Epidermal hyperproliferation, increased VEGF-secretion, accelerated vascularization [103] Increased formation of hyaline cartilage [47] Good transfection efficiency, therapeutic IGF-1 levels, improved cartilage repair [48] Increased bone formation [54] New bone formation [31] Significant bone regeneration after 6 weeks [55] Improved survival of axotomized retinal ganglion cells [104] lacZ-expressing endothelial cells lining luminal graft surface 5 weeks after implantation [78] 
Fig. 2 Combination of bone tissue engineering, gene therapy based on human mesenchymal stem cells (MSCs) and silk fibroin biomaterials to study the impact of viral transfection on MSC osteogenic performance. MSCs were transduced with adenovirus containing a human BMP-2 (Ad-BMP-2) gene at clinically reasonable viral concentrations and cultured for 4 weeks. Controls with non-transfected MSCs, but exposed to exogenous BMP-2 concentrations on an analogous time profile as that secreted by the Ad-BMP-2 group, were compared. Both the Ad-BMP-2 MSC group and the exogenous protein BMP-2 group strongly expressed osteopontin and bone sialoprotein. Cells secreted a matrix that underwent mineralization on the silk fibroin scaffolds, forming clusters of osseous material, as determined by micro-computed tomography. The expression of osteogenic marker proteins and alkaline phosphatase was significantly higher in the Ad-BMP-2 MSC group than in the exogenous protein BMP-2 group, and no significant differences in mineralization were observed in two of the three MSC sources tested.The results demonstrate that transfection resulted in higher levels of expression of osteogenic marker genes, no change in proliferation rate and did not impact the capacity of the cells to calcify tissues on these protein scaffolds.These findings suggest additional options to control differentiation where exogenous additions of growth factors or morphogens can be replaced with transfected MSCs. Light microscopy of construct cross sections after 2 weeks (A-F) or 4 weeks (G-L) of cultivation in osteogenic medium (B, C, E, F, H, I, K, L) or control medium (A, D, G, J). MSC were either transduced with Ad-BMP-2 (center column) or exposed to BMP-2 concentrations as secreted and measured for the Ad-BMP-2 transduced cells (right column) or cultivated in control medium (left column). Sections were stained with H&E (A-C; G-I) or with von Kossa (D-F; J-L).
Bar length is 100 m. Reprinted from [63] , with permission from Elsevier.
electroporation has been reported [20] . [39] , bone [40] , cartilage [41] and nerve regeneration [42] as well as wound healing [43] and muscle repair [44] and demonstrated the potential for extended local production of growth factors. [46] [18] . [49] . Liposomal IGF-1 cDNA delivery showed a therapeutic effect in a rat burn wound model [50] .
Gene therapy applications in tissue engineering
Skin and wound healing
Delayed wound healing caused by diabetes, steroid therapy, peripheral vascular disease as well as impaired function and aesthetics due to excessive scarring caused by burns are among the most common conditions treated by the plastic surgeon. Wound repair is a complex cascade of events that occurs in distinct phases and involves multiple interactions between cytokines, cells and extra-cellular matrix [45]. Skin is an easily accessible tissue, and the high turnover of the epidermis and the fact that a multitude of cytokines and growth factors crucial to the regeneration process undergo short-term up-and down-regulation make it an ideal candidate for gene therapy: short-term gene expression, which is frequently a problem with gene therapy vectors, is desirable when transduction of the skin for wound repair is intended. Keratinocytes and Fibroblasts, the predominant cells of the skin, can easily be harvested and cultured, allowing for in vitro amplification and genetic manipulation. Many different protocols combining gene delivery, sometimes cell-based using ex vivo manipulated skin cells, with a tissue-engineered matrix have been tested. A thorough review on tissue engineering of cultured skin substitutes has recently been published as a part of this review series
Transplantation of fibroblast suspensions transiently transfected with EGF plasmid could accelerate wound re-epithelialization [47]. Another study investigated the combination of a matrix for cell transplantation with a transfection system to release therapeutic proteins in vitro and in vivo. A hEGF-expressing plasmid was incorporated in a fibrin matrix, which was re-suspended with human keratinocytes. After transplantation to full thickness wounds on athymic mice, EGF expression was 180-fold increased compared to controls and persisted for 7 days [48]. Several other growth factors, including IGF-1 and platelet-derived growth factor BB (PDGF-BB) have been delivered to skin by means of gene therapy to stimulate wound healing. Retrovirally transduced human keratinocytes expressing IGF-1 showed an increased proliferative capacity after transplantation into nude mice, but failed to speed up wound healing
Matrices are useful not only as a carrier for keratinocyte or fibroblast transplantation to wounds but also as a vehicle for gene transfer [51] [67] . Recently, the use of spider silk fibres as an innovative material for construction of a nerve conduit has been reported [68] . For nerve regeneration to occur, the presence of cells secreting neurotrophic factors such as nerve growth factor (NGF) is a necessity. Schwann cells appear to be important in this context, apart from their presumptive mechanical role in that they bridge the gap between axonal growth cone migration and basement membrane [69] . Genetically engineered fibroblasts as well as HEK-293 cells were shown to function as alternative sources of NGF [70, 71] . Neuronal progenitor cells [72] and neural stem cells [73] [35] .
Liver and endocrine pancreas
Hepatic cells have an excellent regenerative potential, enabling regeneration of the liver after secretion of up to 70% of the organ [76, 77] [85] . [88] . In a similar context, saphenous vein grafts could be successfully transduced using an adenoviral vector [89] .
Blood vessels
Vascularization (36) . Based on this principle, researchers demonstrated that both adenoviral [92] and plasmid [93] [96] and processed bovine cancellous bone [95] . The [98] .
Optimization and control of gene expression remains a challenge that needs to be addressed given the deleterious effects of inadequately high levels of transgene expression [55] . To address these issues, Yao et 
